These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2507576)

  • 1. In-vitro fertilization and embryo transfer in patients with endometriosis: impact of a gonadotrophin releasing hormone agonist.
    Oehninger S; Brzyski RG; Muasher SJ; Acosta AA; Jones GS
    Hum Reprod; 1989 Jul; 4(5):541-4. PubMed ID: 2507576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
    Daya S
    Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).
    Segars JH; Hill GA; Bryan SH; Herbert CM; Osteen KG; Rogers BJ; Wentz AC
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):327-31. PubMed ID: 2127603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone.
    Testart J; Forman R; Belaisch-Allart J; Volante M; Hazout A; Strubb N; Frydman R
    Hum Reprod; 1989 Feb; 4(2):198-201. PubMed ID: 2521866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometriosis and IVF: are agonists really better? Analysis of 1180 cycles with the propensity score matching.
    Rodriguez-Purata J; Coroleu B; Tur R; Carrasco B; Rodriguez I; Barri PN
    Gynecol Endocrinol; 2013 Sep; 29(9):859-62. PubMed ID: 23875964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression.
    Surrey ES; Katz-Jaffe M; Kondapalli LV; Gustofson RL; Schoolcraft WB
    Reprod Biomed Online; 2017 Aug; 35(2):145-151. PubMed ID: 28601378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation and pregnancy rates in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression.
    Hassiakos D; Toner JP; Muasher SJ; Jones HW
    Hum Reprod; 1990 Nov; 5(8):1004-8. PubMed ID: 2127937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.
    Guo YH; Lu N; Zhang Y; Su YC; Wang Y; Zhang YL; Sun YP
    Contemp Clin Trials; 2012 Nov; 33(6):1206-10. PubMed ID: 22820320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis.
    Tamura H; Takasaki A; Nakamura Y; Numa F; Sugino N
    J Ovarian Res; 2014 Oct; 7():100. PubMed ID: 25331066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of controlled ovarian hyperstimulation delayed, which occurs after functionally pituitary downregulation by depot GnRH agonist, on the outcome of in vitro fertilization and embryo transfer].
    Ma QH; Li SW; Huang ZY; Han ZY; Qiu DS; Han DW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):980-3. PubMed ID: 18095601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-control study on reduced-dose depot versus daily administration of gonadotrophin-releasing hormone agonists for pituitary desensitization in in vitro fertilization cycles.
    Gao J; Xu YW; Miao BY; Zhou CQ
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1901-6. PubMed ID: 25056469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
    Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
    Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH antagonist in older IVF patients. Retrieval rates and clinical outcome.
    Chang PL; Zeitoun KM; Chan LK; Thornton MH; Sauer MV
    J Reprod Med; 2002 Apr; 47(4):253-8. PubMed ID: 12012875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins?
    Pellicer A; Ruiz A; Castellvi RM; Calatayud C; Ruiz M; Tarin JJ; Miró F; Bonilla-Musoles F
    Hum Reprod; 1989 Jul; 4(5):536-40. PubMed ID: 2507575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of gonadotrophin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization.
    Alvarez C; Cremades N; Blasco N; Bernabeu R
    Hum Reprod; 1997 Nov; 12(11):2366-9. PubMed ID: 9436664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis.
    Dicker D; Goldman GA; Ashkenazi J; Feldberg D; Voliovitz I; Goldman JA
    Hum Reprod; 1990 May; 5(4):418-20. PubMed ID: 2113929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature.
    Pinto E; Pinelo S; Osório M; Ferreira C; Serra H; Pires I; Barbosa A; Figueiredo H; Felgueira E; Tavares A
    Gynecol Endocrinol; 2012 Jul; 28(7):545-8. PubMed ID: 22439899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes.
    Qi Q; Luo J; Wang Y; Xie Q
    J Int Med Res; 2020 Jun; 48(6):300060520918474. PubMed ID: 32586174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.